Laura Ivette Velez Irizarry, MD
Family Practice · Castro Valley
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 6
Offices
6 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Irizarry’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A151939 · Current
Licensed to practise in California · since 2017 · expires 2027-06-30 · Universidad Central Del Caribe School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$24,028
Medicare paid this office $24,028 for 184 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 60 | $6,762 | $109 |
| New patient visit (45+ min) | 42 | $5,397 | $128 |
| Short return visit (20+ min) | 49 | $3,782 | $76 |
| New patient visit (30+ min) | 27 | $2,193 | $81 |
| Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | 15 | $2,097 | $140 |
See all 7 services
| Return visit (30+ min) | 60 | $6,762 | $109 |
| New patient visit (45+ min) | 42 | $5,397 | $128 |
| Short return visit (20+ min) | 49 | $3,782 | $76 |
| New patient visit (30+ min) | 27 | $2,193 | $81 |
| Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | 15 | $2,097 | $140 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 18 | $292 | $16 |
| Automated urinalysis test | 14 | $31 | $2 |
Who their Medicare patients are
184 Original Medicare patients in 2024. Average age 74 · Under 65 12% · 85 and older 13% · Women 68% · Also on Medicaid 19% · Health risk score 1.06. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 68% · Diabetes 31% · Chronic kidney disease 24% · Atrial fibrillation 19% · Cancer 17% · Depression 17% · COPD 14% · Coronary heart disease 13% · Heart failure 11% · Stroke 8%.
The office billed $90,147, Medicare allowed $33,857 and paid $24,028; for 301 services of 29 kinds; $103 of it was for drugs given in the office and $23,925 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 184 | 301 | 74 | 1.06 | $90,147 | $24,028 |
| 2023 | 279 | 467 | 72 | 1.05 | $121,877 | $35,166 |
| 2022 | 488 | 678 | 72 | 1.37 | $129,689 | $38,005 |
| 2021 | 414 | 564 | 72 | 1.21 | $108,003 | $36,571 |
| 2020 | 184 | 377 | 70 | 1.19 | $54,410 | $13,233 |
| 2019 | 271 | 757 | 70 | 1.12 | $98,577 | $24,683 |
| 2018 | 211 | 547 | 71 | 1.11 | $58,520 | $16,477 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Return visit (30+ min) | 90 | $10,378 | $115 |
| New patient visit (45+ min) | 63 | $8,407 | $133 |
| Short return visit (20+ min) | 71 | $5,808 | $81 |
| New patient visit (30+ min) | 41 | $3,542 | $86 |
| Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | 11 | $1,414 | $129 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 19 | $955 | $50 |
| Detection test by immunoassay with direct visual observation for influenza virus | 22 | $373 | $16 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 23 | $373 | $16 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 12 | $114 | $9 |
| Automated urinalysis test | 29 | $64 | $2 |
2022: 8 services
| Return visit (30+ min) | 94 | $11,510 | $117 |
| New patient visit (45+ min) | 63 | $8,286 | $132 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 234 | $5,620 | $23 |
| New patient visit (30+ min) | 43 | $4,217 | $98 |
| Short return visit (20+ min) | 45 | $3,767 | $80 |
| Detection test by immunoassay with direct visual observation for influenza virus | 13 | $211 | $16 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 12 | $196 | $16 |
| Automated urinalysis test | 54 | $122 | $2 |
2021: 8 services
| Return visit (30+ min) | 129 | $15,995 | $122 |
| Short return visit (20+ min) | 83 | $7,174 | $84 |
| New patient visit (45+ min) | 28 | $4,283 | $153 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 153 | $3,619 | $23 |
| Long return visit (40+ min) | 11 | $1,935 | $176 |
| Injection of drug or substance under skin or into muscle | 13 | $181 | $14 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 13 | $161 | $12 |
| Automated urinalysis test | 35 | $79 | $2 |
2020: 8 services
| Return visit (30+ min) | 85 | $5,285 | $58 |
| Short return visit (20+ min) | 56 | $3,966 | $70 |
| New patient visit (30+ min) | 12 | $839 | $70 |
| Short return visit | 12 | $583 | $49 |
| Detection test by immunoassay with direct visual observation for influenza virus | 18 | $292 | $16 |
| Injection of drug or substance under skin or into muscle | 21 | $240 | $9 |
| Automated urinalysis test | 14 | $36 | $2 |
| Injection, ketorolac tromethamine, per 15 mg | 12 | $8 | None |
2019: 15 services
| Return visit (30+ min) | 142 | $12,888 | $78 |
| New patient visit (30+ min) | 63 | $4,882 | $77 |
| Short return visit (20+ min) | 25 | $1,524 | $56 |
| Influenza vaccine split virus, preservative free | 22 | $1,186 | $54 |
| Detection test by immunoassay with direct visual observation for influenza virus | 43 | $746 | $16 |
| Injection of drug or substance under skin or into muscle | 52 | $721 | $12 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 21 | $373 | $16 |
| New patient visit (15+ min) | 12 | $313 | $26 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 12 | $154 | $12 |
| Inhalation treatment for airway obstruction or sputum production | 12 | $153 | $13 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 15 | $135 | $8 |
| Automated urinalysis test | 36 | $98 | $2 |
| Injection, ketorolac tromethamine, per 15 mg | 31 | $31 | None |
| Injection, ceftriaxone sodium, per 250 mg | 17 | $26 | None |
| Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 11 | $1 | None |
2018: 11 services
| Return visit (30+ min) | 59 | $5,666 | $83 |
| Short return visit (20+ min) | 55 | $3,038 | $53 |
| New patient visit (30+ min) | 28 | $2,224 | $79 |
| Influenza vaccine split virus, preservative free | 33 | $1,682 | $51 |
| New patient visit (15+ min) | 21 | $934 | $44 |
| Injection of drug or substance under skin or into muscle | 33 | $661 | $17 |
| Detection test by immunoassay with direct visual observation for influenza virus | 26 | $422 | $16 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 15 | $243 | $16 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 11 | $138 | $13 |
| Automated urinalysis test | 33 | $95 | $3 |
| Injection, ketorolac tromethamine, per 15 mg | 17 | $28 | None |
Medicaid work
$796 in 2022
Medicaid paid $796 for 101 billed services this clinician did in 2022, up to 48 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| OFF/OP EST MAY X REQ PHY/QHP | 101 | $796 |
| 2022 | 101 | 1 | 48 | $796 |
| 2021 | 60 | 1 | 25 | $265 |
See the largest Medicaid services in earlier years
2021
| OFF/OP EST MAY X REQ PHY/QHP | 60 | $265 |
Drugs they prescribed that Part D paid
$1,881
Pharmacies billed $1,881 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 138) in 2024. At or below the middle of the specialty; the typical family practice clinician is at 2%.
118 generic and fewer than 11 brand-name prescriptions · $1,881 in drug cost · 64 antibiotic prescriptions to 54 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Albuterol Sulfate Hfa | 15 | $334 | $22 |
| Doxycycline Monohydrate | 18 | $149 | $8 |
| Amoxicillin-Clavulanate Potass | 17 | $75 | $4 |
Year by year
| 2024 | 138 | 99 | 0% (0) | None | $1,881 |
| 2023 | 186 | 144 | None | None | $3,678 |
| 2022 | 182 | 137 | 0% (0) | None | $2,920 |
| 2021 | 172 | 135 | None | 7% | $2,161 |
| 2020 | 104 | 68 | 0% (0) | None | $1,269 |
| 2019 | 226 | 149 | None | 7% | $3,279 |
| 2018 | 151 | 92 | None | None | $12,151 |
| 2017 | 366 | 46 | 0% (0) | None | $32,082 |
| 2016 | 571 | 70 | 0% (0) | None | $40,954 |
| 2015 | 526 | 72 | 0% (0) | None | $39,139 |
| 2014 | 31 | 16 | 0% (0) | None | $1,438 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Amoxicillin-Clavulanate Potass | 28 | $313 | $11 |
| Albuterol Sulfate Hfa | 12 | $245 | $20 |
| Doxycycline Monohydrate | 22 | $237 | $11 |
| Triamcinolone Acetonide | 13 | $92 | $7 |
| Sulfamethoxazole-Trimethoprim | 12 | $40 | $3 |
2022: 4 drugs
| Doxycycline Monohydrate | 21 | $220 | $10 |
| Amoxicillin-Clavulanate Potass | 25 | $209 | $8 |
| Cephalexin | 24 | $106 | $4 |
| Fluconazole | 12 | $29 | $2 |
2021: 7 drugs
| Doxycycline Monohydrate | 26 | $292 | $11 |
| Nitrofurantoin Mono-Macro | 13 | $268 | $21 |
| Amoxicillin-Clavulanate Potass | 11 | $103 | $9 |
| Mupirocin | 14 | $88 | $6 |
| Cephalexin | 15 | $69 | $5 |
| Sulfamethoxazole-Trimethoprim | 11 | $61 | $6 |
| Meloxicam | 17 | $39 | $2 |
2020: 2 drugs
| Doxycycline Monohydrate | 18 | $231 | $13 |
| Nitrofurantoin Mono-Macro | 12 | $179 | $15 |
2019: 6 drugs
| Doxycycline Monohydrate | 37 | $460 | $12 |
| Nitrofurantoin Mono-Macro | 16 | $317 | $20 |
| Amoxicillin-Clavulanate Potass | 21 | $218 | $10 |
| Mupirocin | 14 | $125 | $9 |
| Meloxicam | 20 | $54 | $3 |
| Sulfamethoxazole-Trimethoprim | 13 | $40 | $3 |
2018: 2 drugs
| Amoxicillin-Clavulanate Potass | 12 | $109 | $9 |
| Doxycycline Monohydrate | 12 | $105 | $9 |
2017: 9 drugs
| Januvia | 13 | $4,375 | $337 |
| Atorvastatin | 26 | $351 | $13 |
| Levothyroxine | 18 | $159 | $9 |
| Loperamide | 11 | $138 | $13 |
| Amlodipine Besylate | 32 | $95 | $3 |
| Ondansetron | 17 | $85 | $5 |
| Gabapentin | 11 | $69 | $6 |
| Omeprazole | 15 | $66 | $4 |
| Pravastatin | 16 | $64 | $4 |
2016: 18 drugs
| Advair Diskus | 12 | $5,071 | $423 |
| Loperamide | 18 | $761 | $42 |
| Hydralazine | 11 | $342 | $31 |
| Atorvastatin | 29 | $339 | $12 |
| Levothyroxine | 26 | $272 | $10 |
| Pravastatin | 14 | $253 | $18 |
| Metformin Hcl Er | 13 | $134 | $10 |
| Gabapentin | 18 | $133 | $7 |
| Allopurinol | 14 | $129 | $9 |
| Metformin | 16 | $124 | $8 |
| Amlodipine Besylate | 27 | $120 | $4 |
| Omeprazole | 17 | $114 | $7 |
| Lisinopril | 16 | $66 | $4 |
| Pantoprazole | 13 | $64 | $5 |
| Famotidine | 15 | $53 | $4 |
| Losartan | 13 | $48 | $4 |
| Clopidogrel | 11 | $45 | $4 |
| Furosemide | 11 | $22 | $2 |
2015: 14 drugs
| Levothyroxine | 23 | $322 | $14 |
| Gabapentin | 13 | $266 | $20 |
| Metoprolol | 11 | $266 | $24 |
| Pravastatin | 13 | $216 | $17 |
| Atorvastatin | 15 | $177 | $12 |
| Pantoprazole | 23 | $164 | $7 |
| Metformin | 11 | $153 | $14 |
| Omeprazole | 14 | $141 | $10 |
| Quinapril | 12 | $123 | $10 |
| Furosemide | 26 | $105 | $4 |
| Amlodipine Besylate | 16 | $94 | $6 |
| Losartan | 19 | $83 | $4 |
| Alendronate | 11 | $63 | $6 |
| Lisinopril | 12 | $55 | $5 |
Money from drug and device companies
$16 in 2020
| 2020 | 1 | 1 | None | $16 |
| 2019 | 2 | 2 | None | $39 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| GlaxoSmithKline | Shingrix | $16 | 1 payment
|
See the published payment
| GlaxoSmithKline | Meals · 2020-02-20 | Shingrix | $16 |
See earlier years (2019)
2019: $39
| Boehringer Ingelheim Pharmaceuticals | Spiriva Respimat | $22 | 1 payment
|
| Flexion Therapeutics | Zilretta | $17 | 1 payment
|
Professional record
- NPI
- 1821416157
- Licence
- CA A151939California A151939: Current · expires 2027-06-30
- Trained
- University Central Del Caribe Escuela De Medicina, 2014
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2014-04-03
- NPI last updated
- 2024-02-29
- NPI record certified
- 2024-02-29
This is when the NPI record was last certified, not a medical board exam.